-
公开(公告)号:US20240168117A1
公开(公告)日:2024-05-23
申请号:US18425964
申请日:2024-01-29
发明人: Darin OKUDA
CPC分类号: G01R33/5608 , G01R33/4822 , G01R33/5601 , G06N20/00 , G06T7/11 , G06T2207/10088 , G06T2207/30016 , G06T2207/30096
摘要: 3D MRI images of the brain may be created and acquired. After administration of contrast, brain lesions and other abnormalities may be identified and isolated from the 3D MRI images, with each lesion serving as a region of interest (ROI). 3D region of contrast enhancement images may be created from segmented 3D MRI images and different regions of contrast enhancement of the brain lesion may be depicted. Saved regions of contrast enhancement may be converted into stereolithography format, maximum intensity projection (MIP) images, and/or orthographic projection images. Data corresponding to these resulting 3D region of contrast enhancement images may be used to create 3D printed models of the isolated region of contrast enhancement. Analysis of the 3D brain region of contrast enhancement images and the 3D printed region of contrast enhancement models may enable a more efficient and accurate way of determining brain lesion risk factors and effective treatment regimens.
-
公开(公告)号:US20240161874A1
公开(公告)日:2024-05-16
申请号:US18281085
申请日:2022-03-11
摘要: Provided herein is a machine learning model to reconstitute T cell and B cell selections, and methods of use thereof. The methods provided herein include methods of prediction of the risk of developing an autoimmune disease or disorder, the risk of developing alloimmunity from organ or cellular transplant, the risk of developing graft-versus-host disease (GvHD) from organ or cellular transplant, the risk of developing alloimmunity from an adoptive T cell therapy, the risk of developing alloimmunity from a chimeric antigen receptor (CAR)-T cell therapy, and methods of prediction of the safety of an antibody drug in a subject. Also provided herein is a method of classifying T cell receptor p (TCRp) gene, and methods of use thereof. The methods provided include methods of determining an organ donor/organ recipient compatibility, methods of predicting graft versus host disease (GvHD) in a recipient, acute GvHD (aGvHD), chronic GvHD (cGvHD) and cancer relapse in a subject.
-
公开(公告)号:US20240148666A1
公开(公告)日:2024-05-09
申请号:US18534974
申请日:2023-12-11
发明人: Qiang CHENG , Tuo WEI , Daniel J. SIEGWART
IPC分类号: A61K9/51 , A61K48/00 , C12N9/22 , C12N15/11 , C12N15/113
CPC分类号: A61K9/5123 , A61K48/0033 , C12N9/22 , C12N15/11 , C12N15/111 , C12N15/113 , C12N2310/11 , C12N2310/14 , C12N2310/20 , C12N2320/32
摘要: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
-
公开(公告)号:US11969499B2
公开(公告)日:2024-04-30
申请号:US16618043
申请日:2018-06-15
发明人: Simon Young , David Leach , Jeffrey D. Hartgerink
IPC分类号: A61K9/00 , A61K9/06 , A61K31/7084 , A61K39/00 , A61K39/39 , A61K45/06 , A61K47/42 , A61K47/64 , A61K47/69
CPC分类号: A61K9/0024 , A61K9/06 , A61K31/7084 , A61K39/0011 , A61K39/39 , A61K47/42 , A61K47/64 , A61K47/6903 , A61K2039/55561 , A61K2039/6093 , A61K2039/80 , A61K45/06
摘要: In one aspect, the present disclosure provides for novel compositions of matter comprising multi domain peptide (MDP) hydrogels and cyclic dinucleotides (CDNs). Also disclosed are method of using such compositions in the treatment of cancer, including in particular the treatment of head and neck cancers, such as those resistant to CDN therapy.
-
公开(公告)号:US20240116860A1
公开(公告)日:2024-04-11
申请号:US18508202
申请日:2023-11-13
发明人: Daniel J. SIEGWART , Kejin ZHOU
IPC分类号: C07C321/14 , A61K9/51 , A61K31/7105 , A61K31/7125 , A61K47/20 , A61K47/22 , A61K47/59 , A61K47/60 , A61K47/69 , A61K48/00 , C07C323/52 , C07D295/15
CPC分类号: C07C321/14 , A61K9/513 , A61K9/5146 , A61K31/7105 , A61K31/7125 , A61K47/20 , A61K47/22 , A61K47/59 , A61K47/60 , A61K47/6931 , A61K48/0041 , C07C323/52 , C07D295/15
摘要: Modular dendrimers with cationic groups and lipophilic groups are provided herein. In some aspects, the dendrimers provided herein may be formulated in compositions which contain a nucleic acid and one or more helper excipients. In some aspects, these compositions may also be used to treat diseases or disorders with a therapeutic nucleic acid.
-
公开(公告)号:US20240096493A1
公开(公告)日:2024-03-21
申请号:US18469022
申请日:2023-09-18
申请人: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM , BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
发明人: Matteo Ligorio , Rebecca Napier , William Gasper , Dario Ghersi
CPC分类号: G16H50/20 , G06T7/0012 , G06T7/50 , G16H50/50 , G16H70/60 , G06T2207/20021 , G06T2207/20036 , G06T2207/20081 , G06T2207/30096 , G06T2207/30242
摘要: Aspects of the present disclosure relate to systems and methods for analyzing a tumor, and more specifically, analyzing a tumor to identify a biological aggressiveness of the tumor. One example method for tumor analysis includes: receiving one or more input features associated with a geometric shape of a tumor, the one or more input features including at least a value indicating a circularity of the tumor; determining, via a machine learning component, a characteristic of the tumor based on the one or more input features, the characteristic being indicative of patient survivability; and outputting an indication of the characteristic.
-
公开(公告)号:US20240091323A1
公开(公告)日:2024-03-21
申请号:US18271173
申请日:2022-01-07
发明人: Daniel M. Rosenbaum , Daniel Kober
IPC分类号: A61K38/48 , A61K31/573 , A61K31/675 , A61K47/60 , A61P31/14
CPC分类号: A61K38/4813 , A61K31/573 , A61K31/675 , A61K47/60 , A61P31/14 , C12Y304/17023
摘要: Disclosed herein are ACE2 recombinant proteins and methods of using such for therapeutic and/or diagnostic purposes. Also provided herein are methods for producing such recombinant proteins.
-
公开(公告)号:US20240083842A1
公开(公告)日:2024-03-14
申请号:US18508211
申请日:2023-11-13
发明人: Daniel J. SIEGWART , Kejin ZHOU
IPC分类号: C07C321/14 , A61K9/51 , A61K31/7105 , A61K31/7125 , A61K47/20 , A61K47/22 , A61K47/59 , A61K47/60 , A61K47/69 , A61K48/00 , C07C323/52 , C07D295/15
CPC分类号: C07C321/14 , A61K9/513 , A61K9/5146 , A61K31/7105 , A61K31/7125 , A61K47/20 , A61K47/22 , A61K47/59 , A61K47/60 , A61K47/6931 , A61K48/0041 , C07C323/52 , C07D295/15
摘要: Modular dendrimers with cationic groups and lipophilic groups are provided herein. In some aspects, the dendrimers provided herein may be formulated in compositions which contain a nucleic acid and one or more helper excipients. In some aspects, these compositions may also be used to treat diseases or disorders with a therapeutic nucleic acid.
-
公开(公告)号:US11912758B2
公开(公告)日:2024-02-27
申请号:US17146187
申请日:2021-01-11
发明人: Jean X. Jiang , Zhiqiang An , Ningyan Zhang , Wei Xiong , Manuel A. Riquelme , Sumin Gu , Naomi Ledene Sayre
IPC分类号: C07K16/18 , A61K39/395 , A61P35/00 , A61P25/28 , A61P19/10
CPC分类号: C07K16/18 , A61K39/395 , A61P19/10 , A61P25/28 , A61P35/00 , C07K2317/24 , C07K2317/75 , C07K2317/76
摘要: Antibodies that bind to connexin 43 hemichannels and inhibit, or activate, channel opening are provided. In certain aspects, methods for detecting or treating cancers with antibodies that activate Cx43 channel opening are also provided. Likewise, methods for treating inflammatory diseases (e.g., osteoarthritis) and neurological injuries (e.g., spinal cord injury) with antibodies that inhibit Cx43 channel opening are provided.
-
公开(公告)号:US20240043393A1
公开(公告)日:2024-02-08
申请号:US18158046
申请日:2023-01-23
发明人: Boyu ZHONG , Lijun SUN , Heping SHI , Jing LI , Chuo CHEN , Zhijian CHEN
IPC分类号: C07D277/34 , C07D417/14 , A61K31/429 , A61K31/4365 , A61K31/4439 , A61K31/506 , A61K31/519 , A61K31/427 , C07D277/40 , A61K31/437 , A61K31/426 , A61K31/381 , A61K31/433 , A61K31/4709 , A61K39/39 , A61K45/06 , A61K31/454 , A61K31/4725 , A61K31/497 , A61K31/4985 , A61K31/501 , C07D277/36 , C07D403/06 , C07D417/04 , C07D417/06 , C07D417/10 , C07D417/12 , C07D471/04 , C07D495/04 , C07D513/04
CPC分类号: C07D277/34 , C07D513/04 , A61K31/429 , A61K31/4365 , A61K31/4439 , A61K31/506 , A61K31/519 , A61K31/427 , C07D277/40 , A61K31/437 , A61K31/426 , A61K31/381 , A61K31/433 , A61K31/4709 , A61K39/39 , A61K45/06 , A61K31/454 , A61K31/4725 , A61K31/497 , A61K31/4985 , A61K31/501 , C07D277/36 , C07D403/06 , C07D417/04 , C07D417/06 , C07D417/10 , C07D417/12 , C07D471/04 , C07D495/04 , C07D417/14
摘要: Disclosed are novel compounds of Formula I that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.
-
-
-
-
-
-
-
-
-